These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 29554022

  • 1. Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.
    Sengupta S, Weyand AC, Upadhyaya SA, Wu YM, Robinson DR, Mody RJ.
    J Pediatr Hematol Oncol; 2019 May; 41(4):e263-e265. PubMed ID: 29554022
    [Abstract] [Full Text] [Related]

  • 2. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L, Navrátilová M, Svoboda M, Házová J, Vašíčková P, Sťahlová EH, Fabian P, Schneiderová M, Macháčková E.
    Klin Onkol; 2019 May; 32(Supplementum2):118-122. PubMed ID: 31409087
    [Abstract] [Full Text] [Related]

  • 3. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
    Pilarski R, Cebulla CM, Massengill JB, Rai K, Rich T, Strong L, McGillivray B, Asrat MJ, Davidorf FH, Abdel-Rahman MH.
    Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
    Ewens KG, Lalonde E, Richards-Yutz J, Shields CL, Ganguly A.
    BMC Cancer; 2018 Nov 26; 18(1):1172. PubMed ID: 30477459
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
    Zauderer MG, Jayakumaran G, DuBoff M, Zhang L, Francis JH, Abramson DH, Cercek A, Nash GM, Shoushtari A, Chapman P, D'Angelo S, Arnold AG, Siegel B, Fleischut MH, Ni A, Rimner A, Rusch VW, Adusumilli PS, Travis W, Sauter JL, Zehir A, Mandelker D, Ladanyi M, Robson M.
    J Thorac Oncol; 2019 Nov 26; 14(11):1989-1994. PubMed ID: 31323388
    [Abstract] [Full Text] [Related]

  • 6. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
    Soares de Sá BC, de Macedo MP, Torrezan GT, Braga JCT, Fidalgo F, Moredo LF, Lellis R, Duprat JP, Carraro DM.
    BMC Cancer; 2019 Nov 09; 19(1):1077. PubMed ID: 31706282
    [Abstract] [Full Text] [Related]

  • 7. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
    Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH.
    J Med Genet; 2011 Dec 09; 48(12):856-9. PubMed ID: 21941004
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
    Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK.
    J Natl Cancer Inst; 2018 Dec 01; 110(12):1328-1341. PubMed ID: 30517737
    [Abstract] [Full Text] [Related]

  • 9. A population-based analysis of germline BAP1 mutations in melanoma.
    O'Shea SJ, Robles-Espinoza CD, McLellan L, Harrigan J, Jacq X, Hewinson J, Iyer V, Merchant W, Elliott F, Harland M, Bishop DT, Newton-Bishop JA, Adams DJ.
    Hum Mol Genet; 2017 Feb 15; 26(4):717-728. PubMed ID: 28062663
    [Abstract] [Full Text] [Related]

  • 10. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M, Aspesi A, Biasi A, Casalone E, Ferrante D, Ogliara P, Gironi LC, Giorgione R, Farinelli P, Grosso F, Libener R, Rosato S, Turchetti D, Maffè A, Casadio C, Ascoli V, Dianzani C, Colombo E, Piccolini E, Pavesi M, Miccoli S, Mirabelli D, Bracco C, Righi L, Boldorini R, Papotti M, Matullo G, Magnani C, Pasini B, Dianzani I.
    Cancer Lett; 2016 Aug 10; 378(2):120-30. PubMed ID: 27181379
    [Abstract] [Full Text] [Related]

  • 11. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
    Byrne L, Ingalls C, Ansari A, Porteus C, Donenberg TR, Sussman DA, Cebulla CM, Abdel-Rahman MH.
    Fam Cancer; 2023 Jul 10; 22(3):307-311. PubMed ID: 36513904
    [Abstract] [Full Text] [Related]

  • 12. Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome.
    Lebensohn A, Ghafoor A, Bloomquist L, Royer MC, Castelo-Soccio L, Karacki K, Hathaway O, Maglo T, Wagner C, Agra MG, Blakely AM, Schrump DS, Hassan R, Cowen EW.
    JAMA Dermatol; 2024 Aug 01; 160(8):838-845. PubMed ID: 38759225
    [Abstract] [Full Text] [Related]

  • 13. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
    Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H.
    PLoS One; 2012 Aug 01; 7(4):e35295. PubMed ID: 22545102
    [Abstract] [Full Text] [Related]

  • 14. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
    Cebulla CM, Binkley EM, Pilarski R, Massengill JB, Rai K, Liebner DA, Marino MJ, Singh AD, Abdel-Rahman MH.
    Ophthalmic Genet; 2015 Jun 01; 36(2):126-31. PubMed ID: 25687217
    [Abstract] [Full Text] [Related]

  • 15. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
    Rai K, Pilarski R, Cebulla CM, Abdel-Rahman MH.
    Clin Genet; 2016 Mar 01; 89(3):285-94. PubMed ID: 26096145
    [Abstract] [Full Text] [Related]

  • 16. Germline BAP1 mutations predispose to malignant mesothelioma.
    Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M.
    Nat Genet; 2011 Aug 28; 43(10):1022-5. PubMed ID: 21874000
    [Abstract] [Full Text] [Related]

  • 17. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome.
    Louw A, Creaney J, Thomas A, Van Vliet C, Harvey NT, Wood BA, Mesbah Ardakani N.
    Am J Dermatopathol; 2020 Nov 28; 42(11):872-875. PubMed ID: 32649346
    [Abstract] [Full Text] [Related]

  • 18. Tumours associated with BAP1 mutations.
    Murali R, Wiesner T, Scolyer RA.
    Pathology; 2013 Feb 28; 45(2):116-26. PubMed ID: 23277170
    [Abstract] [Full Text] [Related]

  • 19. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z, Buljan M, Busam KJ.
    J Cutan Pathol; 2015 Jun 28; 42(6):406-12. PubMed ID: 25902915
    [Abstract] [Full Text] [Related]

  • 20. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.
    Cheung M, Talarchek J, Schindeler K, Saraiva E, Penney LS, Ludman M, Testa JR.
    Cancer Genet; 2013 May 28; 206(5):206-10. PubMed ID: 23849051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.